Tools
Stock profile

LifeStance Health Group, Inc. (LFST)

LFST · Latest close $13.77 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$13.77
As of Nov 18, 2026
Tracked funds holding
2 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

LifeStance Health Group, Inc. (LFST) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $758.8M sold). Latest close $13.77 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-758.8M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

OrbiMed Advisors · First Eagle Investment Management — 2 tracked funds hold LFST. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 10 sales ($758.8M). Insider trading

Often held alongside

Strata Critical Medical, Inc. (SRTA) · Pennant Group, Inc. (PNTG) · Privia Health Group, Inc. (PRVA) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
OrbiMed Advisors0.19%947,400ADDED (+89.5%) Q3 filed Nov 16
First Eagle Investment Management0.03%1,562,966TRIMMED (-2.9%) Q3 filed Nov 10

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +24.0% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

14.603.362024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding289 of 8,857 filers
Long-only filers among them285
Change vs 2026 Q1+71 net · 279 entered · 208 exited
Shares reported, all filers375,549,636
Reported value, all filers$4.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryServices-Health Services (SIC 8000)
Revenue · FY2025$1.4B
Net income · FY2025$9.7M
Total assets · FY2025$2.2B
Shares outstanding382,055,609
Market cap (at latest close)$5.3B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 29, 2026.

Short interest

Shares short · Oct 15, 202613,769,507
Share of shares outstanding3.60%
Days to cover4.77

Shares short at recent settlements — Jul 31, 2026: 9.6M · Aug 14, 2026: 11.4M · Aug 31, 2026: 13.6M · Sep 15, 2026: 16.3M · Sep 30, 2026: 15.5M · Oct 15, 2026: 13.8M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 29, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 1K · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 29, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 10 sales by 5 insiders ($758.8M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 16, 2026Burdick Kenneth ASell124,228$14.31$1.8MSEC filing
Nov 12, 2026TPG GP A, LLCSell37,233,110$13.02$484.8MSEC filing
Nov 12, 2026Burdick Kenneth ASell159,624$14.31$2.3MSEC filing
Nov 11, 2026Miller Lisa KChief Operating OfficerSell14,663$14.68$215.3KSEC filing
Nov 10, 2026Pardo RyanSee RemarksSell587,920$14.58$8.6MSEC filing
Nov 10, 2026Pardo RyanSee RemarksSell2,216,585$14.58$32.3MSEC filing
Nov 10, 2026Burdick Kenneth ASell75,000$14.60$1.1MSEC filing
Nov 9, 2026Burdick Kenneth ASell66,589$14.41$959.5KSEC filing
Sep 11, 2026TPG GP A, LLCSell18,409,705$12.29$226.3MSEC filing
Sep 2, 2026Paunovich VukasinChief Technology OfficerSell42,067$12.87$541.4KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 2, 2026Paunovich VukasinOfficer42,067$541.2KSep 2, 2026SEC filing
Aug 14, 2026DeLuca TeresaDirector7,500$95.1KAug 14, 2026SEC filing
Aug 13, 2026DeLuca TeresaDirector20,441$250.0KAug 13, 2026SEC filing
Aug 11, 2026Burdick Kenneth ADirector500,000$5.8MAug 11, 2026SEC filing
Aug 10, 2026TPG VIII Lynnwood Holdings Aggregation, L.P.Stockholder13,643,207$147.9MAug 10, 2026SEC filing
Aug 10, 2026Miller Lisa KOfficer47,912$519.8KAug 10, 2026SEC filing
Aug 10, 2026Paunovich VukasinOfficer44,394$481.7KAug 10, 2026SEC filing
Aug 10, 2026Summit Investors GE IX/VC IV (UK), L.P.Owner1,273$13.5KAug 10, 2026SEC filing
Aug 10, 2026Summit Partners Entrepreneur Advisors Fund II, L.P.Owner1,626$17.3KAug 10, 2026SEC filing
Aug 10, 2026Summit Investors GE IX-VC IV, LLCOwner12,165$129.2KAug 10, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 14, 2026TPG GP A, LLCSC 13G/A98,101,40725.7%Jun 30, 2026SEC filing
Aug 11, 2026Summit Partners, L.P.SC 13G/A23,310,1156.1%Jun 30, 2026SEC filing
Jul 29, 2026BlackRock, Inc.SC 13G32,034,4648.3%Jun 30, 2026SEC filing
May 15, 2026TPG GP A, LLCSC 13G/A111,744,61429.3%Mar 31, 2026SEC filing
May 8, 2026Summit Partners, L.P.SC 13G/A29,209,7767.5%Mar 31, 2026SEC filing
May 6, 2026FMR LLCSC 13G/A58,467,479.6915.0%Mar 31, 2026SEC filing
Feb 5, 2026FMR LLCSC 13G/A46,706,784.112.0%Dec 31, 2025SEC filing
Nov 13, 2025Summit Partners, L.P.SC 13G/A33,524,7158.6%Sep 30, 2025SEC filing
Nov 7, 2025FMR LLCSC 13G/A39,249,054.0210.1%Oct 31, 2025SEC filing
Nov 5, 2025FMR LLCSC 13G/A38,844,756.4410.0%Sep 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Services-Health Services (SIC 8000). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Growth — Latest revenue: $1.4B · 5-yr revenue CAGR: 37.3% · Straight growth years: 5

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Share count tripled (3x)1100.0%+6.2%+5.6%+0.6%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold LFST — ranked by lift, the co-holding pattern described in Methodology: Strata Critical Medical, Inc. (SRTA) · Pennant Group, Inc. (PNTG) · Privia Health Group, Inc. (PRVA) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · Brookdale Senior Living Inc. (BKD) · Acadia Healthcare Company, Inc. (ACHC).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 12, 20268.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Nov 5, 20262.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Oct 16, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain OfficersSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Strata Critical Medical, Inc. (SRTA) · Track Record: how the signals scored · Practice timing on LFST

One email a week: the week’s new filings and research. Subscribe free

← LEVI  ·  LFUS →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.